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Cytosolic a-mannosidases are glycosyl hydrolases that participate in the catabolism of cytosolic
free N-oligosaccharides. Two soluble a-mannosidases (E-I and E-II) belonging to glycosyl
hydrolases family 47 have been described in Candida albicans. We demonstrate that addition of
pepstatin A during the preparation of cell homogenates enriched a-mannosidase E-I at the
expense of E-II, indicating that the latter is generated by proteolysis during cell disruption. E-I
corresponded to a polypeptide of 52 kDa that was associated with mannosidase activity and was
recognized by an anti-a1,2-mannosidase antibody. The N-mannan core trimming properties of the
purified enzyme E-I were consistent with its classification as a family 47 a1,2-mannosidase.
Differential density-gradient centrifugation of homogenates revealed that a1,2-mannosidase E-I
was localized to the cytosolic fraction and Golgi-derived vesicles, and that a 65 kDa membrane-
bound a1,2-mannosidase was present in endoplasmic reticulum and Golgi-derived vesicles.
Distribution of a-mannosidase activity in a kex2D null mutant or in wild-type protoplasts treated
with monensin demonstrated that the membrane-bound a1,2-mannosidase is processed by Kex2
protease into E-I, recognizing an atypical cleavage site of the precursor. Analysis of cytosolic
free N-oligosaccharides revealed that cytosolic a1,2-mannosidase E-I trims free Man8GlcNAc2
isomer B into Man7GlcNAc2 isomer B. This is believed to be the first report demonstrating the
presence of soluble a1,2-mannosidase from the glycosyl hydrolases family 47 in a cytosolic
compartment of the cell.
INTRODUCTION
N-Glycosylation is one of the most common post-trans-
lational modifications of proteins in eukaryotic cells. The N-
glycosylation pathway begins in the endoplasmic reticulum
(ER), where the dolichol-bound Glc3Man9GlcNAc2 oligo-
saccharide is assembled, then transferred to nascent proteins
and processed by a-glycosidases which remove the three
glucose residues and one mannose residue to generate the
Man8GlcNAc2 oligosaccharide (Herscovics, 1999a, b). In
mammalian cells, N-oligosaccharides are further modified to
complex glycans by different Golgi glycosyl hydrolases and
transferases, whereas in lower eukaryotes such as
Saccharomyces cerevisiae the only further modifications are
by Golgi mannosyl transferases that lead to the biosynthesis
of high mannose oligosaccharides (Herscovics, 1999a, b).
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N-glycan biosynthesis, and in the degradation of N-
oligosaccharides carried out in the cytosol and acidic
compartments such as vacuoles and lysosomes (Daniel
et al., 1994; Herscovics, 1999b). These enzymes are also
involved in the endoplasmic-reticulum-associated degrada-
tion (ERAD) as part of the glycoprotein quality control
systems (Helenius & Aebi, 2004). a-Mannosidases are
grouped into glycosyl hydrolase families 38 (EC 3.2.1.24/
EC 3.2.1.114) and 47 (EC 3.2.1.113) (Henrissat & Davis,
1997). Members of family 47 are membrane-bound a1,2-
mannosidases. Depending on substrate specificity, two
types of enzymes can be recognized in the family: those that
reside in the ER of yeast and mammalian cells, eliminating
a mannose unit from Man9GlcNAc2 (M9) to form
Man8GlcNAc2 isomer B (M8B) (Herscovics, 1999a, b),
and the Golgi a1,2-mannosidases IA, IB and IC, which
release the four a1,2-linked mannoses from M9 to produce
Man5GlcNAc2 (Herscovics, 1999b; Tremblay & Herscovics,
2000).
Golgi a-mannosidases II, IIx and III, along with lysosomal,
vacuolar acidic and cytosolic/ER neutral a-mannosidases,
compose family 38. These enzymes are inhibited by
swainsonine and can release a1,2-, a1,3- and a1,6-linked
mannose residues (Daniel et al., 1994; Herscovics, 1999b).
In lower eukaryotes, cytosolic a-mannosidase activity has
not been reported; however, in mammals these enzymes
have been studied extensively (Dutta & Majumder, 1984;
Tulsiani & Touster, 1987; Haeuw et al., 1991; De Gasperi
et al., 1992). These neutral cytosolic a-mannosidases
participate in the hydrolysis of free N-oligosaccharides,
which are generated by the ERAD of misfolded N-
glycoproteins and by cleavage of dolichol-linked oligosac-
charides (Spiro, 2004; Suzuki et al., 2006). This activity is
not sensitive to 1-deoxymannojirimycin (1-DMJ), but is
inhibited by swainsonine (Tulsiani & Touster, 1987;
Haeuw et al., 1991) and activated by Co
2+ (Dutta &
Majumder, 1984; Haeuw et al., 1991; De Gasperi et al.,
1992; Weng & Spiro, 1996). Two cytosolic a-mannosidases
have been described in rat liver. One trims Man9GlcNAc
into Man8GlcNAc and Man7GlcNAc as the ER a1,2-
mannosidase hydrolyses this oligosaccharide, suggesting
that it could be a soluble form of the ER enzyme (Grard
et al., 1994). The other is a neutral a-mannosidase involved
in the catabolism of cytosolic N-oligosaccharides released
from ER (Grard et al., 1996). Studies of rat liver ER a-
mannosidase II, which has catalytic and immunological
properties similar to the cytosolic a-mannosidase, suggest
that the cytosolic enzyme may be derived from the ER
membrane-bound form (Bischoff & Kornfeld, 1986; Weng
& Spiro, 1996). cDNA sequences of rat and mouse ER/
cytosolic a-mannosidase indicate that they encode soluble
proteins, lacking signal sequences, and have homology to
the vacuolar a-mannosidase from S. cerevisiae and other
family 38 mannosidases (Bischoff et al., 1990; Costanzi
et al., 2006). It has been suggested that this enzyme is
synthesized in the cytoplasmic compartment, and then
transported to the ER by a mechanism that involves
proteolytic processing (Weng & Spiro, 1996; Spiro, 2004).
Proteolytic processing also occurs with the vacuolar a-
mannosidase from S. cerevisiae during import from the
cytoplasmic compartment to the vacuolar lumen
(Yoshihisa & Anraku, 1990).
We have previously purified and characterized two soluble
a-mannosidases, E-I and E-II, from the human-pathogenic
fungus Candida albicans. These represent 20% and 80% of
the total soluble activity, respectively (Va ´zquez-Reyna et al.,
1999; Mora-Montes et al., 2004). Based on the hydrolysis of
natural substrates, we proposed that both proteins are a1,2-
mannosidases belonging to family 47 of glycosyl hydro-
lases, and that these may be involved in N-glycan
processing (Mora-Montes et al., 2004, 2006). We have
demonstrated that E-I and a membrane-bound a-manno-
sidase activity can be converted into E-II by a proteolytic
activity sensitive to pepstatin A (Mora-Montes et al., 2006).
Here, we studied the intracellular localization of a1,2-
mannosidases of C. albicans. A 65 kDa membrane-bound
a1,2-mannosidase was localized in the ER- and Golgi-
derived vesicles, and a1,2-mannosidase E-I in the cytosolic
and Golgi compartments. However, we found that enzyme
E-II is an in vitro artefact generated by proteolysis during
the preparation of cell extracts. Our data indicate that ER
membrane-bound a1,2-mannosidase is processed into
cytosolic enzyme E-I by Kex2, recognizing an atypical
cleavage site. Analysis of the cytosolic fraction of C.
albicans revealed that E-I is involved in the processing of
free M8B to Man7GlcNAc2 isomer B (M7B) N-oligosac-
charide. This study appears to be the first report of an a1,2-
mannosidase of family 47 in the cytosolic compartment of
a lower eukaryote.
METHODS
Materials. M9,M 8B, M7B, Man5GlcNAc2-Asn, 4-methylumbelliferyl-
a-D-mannopyranoside (MUaMan), 4-(2-aminoethyl)benzenesulfonyl
fluoride (AEBSF), E64, 1,10-phenanthroline, PMSF, pepstatin A,
EGTA, lyticase, sucrose, 3,39-diaminobenzidine, BSA, monensin,
monoclonal anti-rat Golgi 58K protein produced in mouse and
anti-mouse IgG-horseradish peroxidase antibody generated in goat
were obtained from Sigma. A cocktail of protease inhibitors was
obtained from Roche. Anti-yeast carboxypeptidase Y (CPY), anti-rat
calnexin and anti-yeast hexokinase I polyclonal sera, all generated in
rabbit, were from USBiological. Anti-rabbit IgG-horseradish perox-
idase antibody generated in donkey was from Amersham Biosciences.
Sepharose CL6B and Sephadex G-25 were from Pharmacia LKB.
DEAE Bio-Gel A and Bio-Gel P-6 were purchased from Bio-Rad. All
other chemicals were of the highest purity commercially available.
Organisms and culture conditions. Candida albicans ATCC 26555,
CAI4 (Fonzi & Irwin, 1993), SC5314 (Gillum et al., 1984), NGY152
(CAI4-CIp10) (Brand et al., 2004), HMY5 (mns1D-CIp10), HMY6
(mns1D-CIp10-MNS1) (Mora-Montes et al., 2007) and kex2D null
mutant (Newport et al., 2003), Candida glabrata ATCC 2001, C.
glabrata kex2D null mutant (Bader et al., 2001) and Saccharomyces
cerevisiae X2180-1A (ATCC 26786) were used in this study. They were
maintained and propagated in YPD medium [1% (w/v) yeast extract,
a1,2-Mannosidase E-I from C. albicans
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previously (Mora-Montes et al., 2004). C. albicans ATCC 26555 was
utilized for all experiments unless otherwise indicated.
Preparation of cell-free extracts and enzyme purification. Cell-
free homogenates were prepared while maintaining all solutions at
4 uC. C. albicans yeast cells were collected by low-speed centrifu-
gation, washed twice and resuspended in 50 mM MES/Tris buffer,
pH 6.0 (buffer A), with or without protease inhibitors and were
broken in a Braun MSK cell homogenizer using 0.45 mm diameter
glass beads. The homogenate was centrifuged at 1000 g for 10 min
and the supernatant was collected and further centrifuged at 105000 g
for 1 h (ultracentrifugation). The high-speed supernatant was
collected, freeze-dried and kept at –20 uC until use. In some
experiments, the pellet, consisting of a mixed-membrane fraction,
was resuspended in buffer A and used to assay a-mannosidase
activity.
For enzyme E-I purification, the high-speed supernatant obtained in
the presence of 1 mM pepstatin A was purified by size-exclusion,
anionic-interchange and concanavalin A-Sepharose affinity chro-
matography as described previously (Mora-Montes et al., 2006). To
purify the membrane-bound a-mannosidase from C. albicans, C.
glabrata and S. cerevisiae, the mixed-membrane fraction was
incubated for 1 h at 48 uC, followed by incubation at 220 uC for
30 min. This procedure solubilized about 50% of the non-enzymic
protein present in the mixed-membrane fraction, without signific-
antly affecting the total a-mannosidase activity remaining in the
pellet. Then, the preparation was ultracentrifuged, and the pellet was
recovered, resuspended in 1 ml of buffer A with 3 mM EDTA,
incubated 1 h at room temperature and ultracentrifuged as indicated.
The pellet was resuspended in 1 ml buffer A containing 0.5 M NaCl,
incubated for 1 h at room temperature and ultracentrifuged. Finally,
the pellet was resuspended in 1 ml buffer A added with Triton X-100
in a protein:detergent ratio of 1:1, and was incubated for 1 h at
room temperature and ultracentrifuged. The pellet was then
resuspended in 1 ml buffer B (50 mM Tris, 0.2 M KCl, 1 mM
CaCl2, 0.01% Triton X-100, pH 7.2) and kept at 220 uC until use.
a-Mannosidase assay. Enzyme activity was measured using either
the fluorogenic substrate MUaMan or the natural oligosaccharides
M9,M 8B or Man5GlcNac2-Asn, essentially as described previously
(Mora-Montes et al., 2004).
Protein determination. Protein was measured by absorbance at
280 nm and by the method of Bradford (1976) using BSA as a
standard.
Electrophoresis. SDS-PAGE was carried out using 10% gels
following standard protocols (Laemmli, 1970), and proteins were
stained with Coomassie blue (Merril, 1990). Zymogram analysis in
SDS-PAGE, using the fluorogenic substrate MUaMan, was performed
for the enzyme detection as described previously (Mora-Montes et al.,
2004).
Protoplast generation and differential centrifugation of homo-
genates. Protoplasts were obtained following the protocol described
by Ramı ´rez et al. (1989). Briefly, yeast cells were collected by low-
speed centrifugation, resuspended at an OD600 of 2–3 in buffer C
(50 mM Tris/HCl buffer, pH 7.5, 1 M sorbitol, 0.8 M KCl and
10 mM MgSO4), lyticase (0.25 mg ml
21) and 15 mM b-mercap-
toethanol. After incubation at 37 uC for 30 min, nearly 100% of the
cells had been converted into protoplasts. These were washed twice
with buffer C and resuspended in 10 mM phosphate buffer, pH 6.0,
containing 3.0 mM MgCl2 (buffer D). Samples of protoplasts were
lysed with a Potter–Elvehjem and pestle (8–10 strokes) and the lysates
were centrifuged at 1000 g for 10 min. The resulting supernatants
were collected and 4 ml aliquots were loaded onto the top of a 35 ml,
continuous 10–65% (w/w) sucrose density gradient prepared with
buffer D and centrifuged at 232000 g for 4 h at 4 uC using a VTi 50
rotor (Beckman Coulter). Gradients were fractionated from the top
and 1 ml fractions were collected. Alternatively, the protoplasts were
incubated with 10 mM monensin for 1 h at 37 uC and lysed as
described above.
Determination of free N-oligosaccharides in the cytosol.
Homogenates of protoplasts of C. albicans, C. glabrata or S. cerevisiae,
treated or untreated with monensin, were fractionated in a
continuous 10–65% (w/w) sucrose density gradient as indicated
above. The soluble fraction (typically fractions 1–4) was saved, freeze-
dried, resuspended in 150 ml deionized water and applied onto a
column (0.36105 cm) of Bio-Gel P-6. Fractions of 120 ml were
collected and those enriched with the oligosaccharides were pooled,
and analysed by high-performance anion-exchange chromatography
as described previously (Mora-Montes et al., 2004).
Antibodies. The anti-a1,2-mannosidase antibody was generated
from recombinant protein as follows. The open reading frame of the
C. albicans MNS1 gene (GenBank/EBI accession AY167027) was
cloned into the bacterial expression vector pET100/D-TOPO
(Invitrogen), overexpressed in Escherichia coli and the recombinant
protein was purified. Antibodies were raised in a male New Zealand
White rabbit after intramuscular injection of 150 mg protein
emulsified with complete Freund’s adjuvant (day 0). Booster
injections were given (150 mg protein emulsified with incomplete
Freund’s adjuvant) on days 15, 30, 45 and 60 and the animal was bled
on day 75.
Anti-calnexin, anti-a1,2-mannosidase, rabbit pre-immune serum,
anti-CPY, anti-hexokinase I and anti-Golgi primary antibodies were
diluted 1:1000, 1:3000, 1:3000, 1:5000, 1:5000 and 1:5000,
respectively, in PBS. The secondary, anti-mouse IgG-horseradish
peroxidase and anti-rabbit IgG-horseradish peroxidase antibodies
were diluted 1:2000 in PBS.
Immunoblots. Purified protein or samples (10 mg) of each a-
mannosidase peak, separated after density-gradient fractionation of
protoplast homogenates, were subjected to SDS-PAGE (10%) and
electrophoretically transferred to Hybond-C extra nitrocellulose
membranes following standard protocols. The membranes were
stained with Ponceau S Red to assess the efficiency of transfer. The
membranes were blocked with 1% BSA in PBS for 2 h, washed three
times with 0.05% Tween 20 in PBS for 10 min, and the primary
antibody was added and incubated for 2 h at room temperature.
Membranes were then washed three times with 0.05% Tween 20 in
PBS for 10 min, incubated for 2 h with the secondary antibody, and
washed twice with 0.05% Tween 20 in PBS for 10 min and once with
PBS for 10 min. Bands were revealed with 3,39-diaminobenzidine
(0.5 mg ml
21) and 3% hydrogen peroxide in PBS. Reactions were
stopped with deionized water.
Preparation of Kex2 enzymes. S. cerevisiae and C. glabrata
secreted, soluble Kex2 proteins were produced in a commercial
Pichia pastoris expression system (Invitrogen). The strain expressing
S. cerevisiae Kex2 was a kind gift of G. Boileau (Lesage et al., 2001).
The C. glabrata enzyme was produced in a similar manner. The C.
albicans secreted, soluble form of the enzyme was expressed from the
ACT1 promoter in C. albicans strain CAI4. All enzyme preparations
were purified by a combination of size-exclusion and anion-exchange
chromatography and tested with specific substrates and inhibitors to
ascertain their specificity (O. Bader & B. Hube, unpublished data).
Proteolytic cleavage of membrane-bound a-mannosidase.
Twenty micrograms of protein from peak 2 and peak 3, obtained
H. M. Mora-Montes and others
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in 50 ml buffer D added with 0.5% Triton X-100, with or without
protease inhibitors, and incubated for 1 h at 37 uC with gentle
shaking. The reactions were analysed by immunoblotting using the
anti-a1,2-mannosidase antibody. For the processing using recombin-
ant Kex2, 20 mg of the partially purified membrane-bound a-
mannosidase and 3 mg of recombinant Kex2 from S. cerevisiae, C.
albicans or C. glabrata were resuspended in buffer B in a final volume
of 20 ml, and incubated for 1 h at 37 uC with gentle shaking. Then,
the reactions were applied to 4–12% NuPAGE Bistris gels
(Invitrogen) and analytic zymograms were carried out (see above).
N-terminal sequencing. The purified a-mannosidase E-I and the
52 kDa a-mannosidase generated by Kex2 were subjected to double-
dimension electrophoresis using isoelectrofocusing ZOOM pH 4–7
strips and 4–12% NuPAGE Bistris ZOOM gels (Invitrogen). The
gels were washed three times with buffer A added with 1% Triton X-
100 for 20 min at room temperature, and a-mannosidase activity
was detected after incubation with buffer A added with 40 mM
MUaMan for 1 h at 37 uC. The proteins were transferred to a PVDF
membrane and N-terminal sequencing was carried out by
BioSynthesis.
RESULTS
Effect of protease inhibitors on intracellular
distribution of a-mannosidase activity
Yeast cells of C. albicans were broken in the presence of
protease inhibitors and the resulting homogenates were
subjected to ultracentrifugation. a-Mannosidase activity
was measured in the high-speed supernatant and in the
mixed-membrane fraction. The results, summarized in
Table 1, indicate that of the inhibitors tested, only
pepstatin A affected the subcellular distribution of the
enzyme. In the absence of pepstatin A, a-mannosidase was
recovered mostly in the supernatant (78–82%) while only
18–22% remained associated with the membrane fraction.
However, in homogenates prepared in the presence of
pepstatin A, total activity was distributed in approximately
equal proportions in the soluble (44%) and membrane
(56%) fractions.
The ratio of the soluble E-I and E-II enzymes could be
determined after separation of these two soluble activities
by ion-exchange chromatography. In the presence of
pepstatin A, only a single peak of a-mannosidase
representing E-I was eluted by 0.1 M NaCl from a DEAE
Bio-Gel A column. After eluting with 0.125 M NaCl, a
second barely detectable peak corresponding to a-manno-
sidase E-II was obtained (Fig. 1).
The enzyme E-I was purified from pepstatin A-treated
extracts using a combination of size-exclusion, ion-
exchange and affinity chromatography as described
previously (Mora-Montes et al., 2006). Following this
protocol, the enzyme E-I was purified 230-fold with a
recovery of 34% of the starting material (Table 2).
Analytical electrophoresis of the purified sample revealed
the presence of two polypeptides, of 23 and 52 kDa
(Fig. 2a). Only the latter was active on the fluorogenic
substrate MUaMan as revealed by zymogram analysis
(Fig. 2b), and was recognized by the anti-a1,2-mannosidase
antibody (Fig. 2c). No immunorecognition was observed in
samples containing pre-immune serum or lacking the
primary antibody (Fig. 2d, e).
The processing of natural substrates such as M9 oligosac-
charide by the purified enzyme was similar to that
described previously (Mora-Montes et al., 2006). This
resulted in the production of M8B and mannose as the sole
products of hydrolysis after 12 h of incubation, and M7B
and Man6GlcNAc2 after 24 h of incubation (data not
shown). As was described for a-mannosidases E-I and E-II
(Mora-Montes et al., 2004, 2006), the purified enzyme did
not hydrolyse Man5GlcNAc2-Asn oligosaccharide (data not
shown) and was more sensitive to 1-DMJ than to
swainsonine, with IC50 values of 0.22 mM and 0.54 mM,
respectively.
Subcellular localization of a-mannosidase E-I
To investigate the subcellular localization of enzyme E-I,
gently disrupted protoplasts of C. albicans were subjected
Table 1. Effect of several protease inhibitors on the subcellular distribution of a-mannosidase activity in
C. albicans
Inhibitor Total a-mannosidase activity* [nmol
MU min
”1 (mg total protein)
”1]
Percentage of total activity
Supernatant MMFD
None 45±68 1 ±31 9 ±3
E64 (10 mM) 49±48 0 ±22 0 ±2
AEBSF (1 mM) 51±78 2 ±41 8 ±4
1,10-Phenanthroline (20 mM) 48±57 9 ±22 1 ±2
Pepstatin A (1 mM) 42±74 4 ±25 6 ±2
Inhibitor cocktaild 49±87 8 ±32 2 ±3
*As measured with MUaMan as substrate. The values represent the means±SD of at least three independent cultures.
DMixed-membrane fraction.
dInhibitor of serine, cysteine and metalloproteases.
a1,2-Mannosidase E-I from C. albicans
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gradient (see Methods). a-Mannosidase activity was
distributed in three peaks associated with fractions 1–4
(peak 1), 21–22 (peak 2) and 26–27 (peak 3) with
corresponding densities of 1.033±0.002 g cm
23,
1.130±0.007 g cm
23 and 1.183±0.004 g cm
23 and
representing 20%, 27% and 53% of total recovered
activity, respectively (Fig. 3a). Centrifugation of a homo-
genate from protoplasts of S. cerevisiae under the same
conditions resulted in separation of two peaks of a-
mannosidase activity associated with fractions 21–22 (peak
2) and 26–27 (peak 3) with corresponding densities of
1.137±0.006 g cm
23 and 1.184±0.006 g cm
23, respect-
ively. Peaks 2 and 3 represented 26% and 74% of total
recovered activity, respectively (Fig. 3b).
Immunoblot assays using antibodies against a1,2-manno-
sidase and several organelle-marker proteins were carried
out to determine the presence of a-mannosidase E-I in the
peaks observed in Fig. 3(a). The results, illustrated in Fig. 4,
indicate that the anti-a1,2-mannosidase antibody detected
a polypeptide of 52 kDa in peaks 1 and 2, which
corresponds to the molecular mass of a-mannosidase E-I
(see above). The same antibody detected trace amounts of
a 65 kDa protein in peak 2 which was enriched in peak 3.
Hexokinase I, a cytosolic marker (Huh et al., 2003), was
only detected in peak 1, while a Golgi marker was barely
detected in peak 1 but was abundant in peak 2. CPY, a
marker of acid vacuoles (Bryant & Stevens, 1998), was
present in peaks 2 and 3, and calnexin, an ER marker
(Parlati et al., 1995), was only detected in peak 3. Mock
controls containing pre-immune serum or lacking the
primary antibodies run in parallel gave no detectable
signals. Therefore E-I was enriched in cytosolic and Golgi
compartments. The anti-a1,2-mannosidase antibodies
detected a 67 kDa polypeptide in both a-mannosidase
peaks separated on sucrose density gradients of extracts
from protoplasts of S. cerevisiae (Fig. 4). Results with
organelle markers were similar to those obtained with a-
mannosidase peaks from the C. albicans preparation. These
results confirmed that S. cerevisiae had only one a1,2-
mannosidase, whereas C. albicans had two isoforms of
a1,2-mannosidase.
An anti-a1,2-mannosidase antibody was raised against the
MNS1 product (see Methods), which is a 65 kDa a1,2-
mannosidase that is predicted to be localized in the ER
(Mora-Montes et al., 2007). Western analysis showed that
Mns1 and a1,2-mannosidase E-I were both detected by this
antibody. In order to demonstrate that both a1,2-
mannosidase isoforms are encoded by MNS1, immunoblot
assays using anti-a1,2-mannosidase antibodies and cell
homogenate from a mns1D null mutant were carried out.
Neither protein was detected in cell homogenates from
mns1D null mutant (Fig. 5, lane 2), whilst two protein
bands with molecular masses of 65 and 52 kDa were
Table 2. Purification of a1,2-mannosidase E-I from C. albicans
Fraction Total protein
(mg)
Activity Purification
(n-fold)
Yield (%)
Specific* Total
High-speed supernatant 1010.0 0.05 50.5 1 100
Sepharose CL6B 125.8 0.8 96.6 16 191
DEAE Bio-Gel A 12.1 3.0 37.5 60 74
Sephadex G-25 10.8 3.4 36.7 68 73
DEAE Bio-Gel A 4.9 6.1 29.9 122 59
Con A-Sepharose 4B 1.9 10.9 20.7 218 41
Sephadex G-25 1.5 11.5 17.3 230 34
*Expressed as nmol MU min
21 (mg protein)
21.
Fig. 1. Separation of a-mannosidase E-I by ion-exchange
chromatography. High-speed supernatant from pepstatin A-
treated homogenates was separated by gel filtration in
Sepharose CL6B and the enzyme fraction obtained was applied
on a column (2.8 7.3 cm) of DEAE Bio-Gel A equilibrated with
buffer A. After washing with the same buffer, bound proteins were
eluted with a discontinuous gradient of 0–4.0 M NaCl in buffer A.
Fractions were collected and used to monitor elution of protein
(filled symbols) and enzyme activity [nmol MU min
”1 (mg
protein)
”1] using MUaMan as substrate (open symbols).
H. M. Mora-Montes and others
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the wild-type strain (Fig. 5, lane 1) and the reintegrant
control (Fig. 5, lane 3). Control assays using pre-immune
serum did not give any detectable signal (Fig. 5, lanes 4 and
5). Additionally, the mns1D null mutant did not show any
hydrolytic activity towards the natural substrate M9 (data
not shown). Therefore, MNS1 encodes both 65 kDa and
52 kDa, a1,2-mannosidase isoforms.
Effect of monensin on the localization of soluble
a1,2-mannosidase
The results in Fig. 4 indicate that a1,2-mannosidase E-I is
associated with the cytosolic and Golgi markers, whereas a
65 kDa a1,2-mannosidase was enriched in the ER and to a
lesser extent in Golgi fractions. To determine whether E-I
was generated from the 65 kDa protein, the effect of
monensin on a1,2-mannosidase localization was analysed.
Monensin, a monovalent ion-selective ionophore, blocks
the transport of vesicles from the medial to the trans
cisternae of the Golgi complex (Rosa et al., 1992), leading
to an accumulation of proteins in the ER. Protoplasts of C.
albicans were incubated with 10 mM monensin (see
Methods) before their disruption and fractionation in a
continuous 10–65% sucrose density gradient. Under these
conditions, the a-mannosidase activity was not affected
(data not shown) and was again distributed in three peaks
with corresponding densities of 1.032±0.003 g cm
23 for
peak 1 (fractions 1–3), 1.139±0.007 g cm
23 for peak 2
(fractions 22–23), and 1.184±0.002 g cm
23 for peak 3
(fractions 27–28). The a-mannosidase activity associated
with peaks 1 and 2 was significantly decreased to 3% and
6%, respectively, and the rest of the recovered a-
mannosidase activity (91%) was associated with peak 3
(Fig. 6a). Anti-a1,2-mannosidase antibodies barely
detected a-mannosidase E-I in peaks 1 and 2, whereas
the 65 kDa a1,2-mannosidase was abundant in peak 3 (not
shown). When protoplasts of S. cerevisiae were treated in
the same way, the a-mannosidase activity was distributed
Fig. 3. Distribution of a-mannosidase activity after density-
gradient centrifugation of homogenates from C. albicans and S.
cerevisiae. Protoplasts from C. albicans (a) or S. cerevisiae (b)
were prepared and homogenized as described in Methods. A 4 ml
sample of each homogenate was loaded onto the top of a 35 ml,
continuous 10–65% (w/w) sucrose density gradient and cen-
trifuged at 232000 g at 4 6C for 4 h in a VTi 50 rotor. The gradient
was fractionated from the top and 1 ml fractions were collected.
These were used to monitor enzyme activity [nmol MU min
”1 (mg
protein)
”1] using MUaMan as substrate (open symbols) and the
sucrose concentration (filled symbols). Fraction 1 corresponds to
the top of the gradient.
Fig. 2. Analytical zymogram and immunodetection of purified a-
mannosidase. The purified enzyme (10 mg) was analysed by SDS-
PAGE (10%) either after heat denaturation (a) or without heating
(b) and separated by electrophoresis. Lane (a) was stained with
Coomassie blue and lane (b) was incubated with MUaMan, as
described in the text, to reveal the a-mannosidase activity. After
separation by SDS-PAGE, proteins were electrotransferred to
nitrocellulose membranes and immunodetected with anti-a1,2-
mannosidase antibody (c), rabbit pre-immune serum (d) or anti-
rabbit IgG-horseradish peroxidase antibody (e).
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27–28 (peak 3) with corresponding densities of
1.140±0.003 g cm
23 and 1.186±0.005 g cm
23, respect-
ively. As for the monensin-treated protoplasts of C.
albicans, there was a redistribution of the a-mannosidase
activity associated with peaks 2 and 3, representing 4% and
96% of total recovered activity, respectively (Fig. 6b).
These results suggest that a-mannosidase E-I is generated
from the 65 kDa a1,2-mannosidase by proteolysis in the
Golgi compartment. Supporting this, we found that
proteolytic processing of the 65 kDa a1,2-mannosidase to
the 52 kDa form occurred if we used ER vesicles from
monensin-treated cells as a source of the a1,2-mannosi-
dase, and Golgi vesicles as a source of the processing
protease (Fig. 7). The generation of 52 kDa a1,2-manno-
sidase E-I depended on addition of Triton X-100 to the
incubations to solubilize the proteins from the vesicles
(data not shown).
In order to establish the nature of the proteolytic activity,
similar experiments were carried out in the presence of
protease inhibitors (Fig. 7). Addition of PMSF at 0.5 mM
(panel a, lane 4) or 1.0 mM (panel a, lane 5) was unable to
prevent the generation of a1,2-mannosidase E-I; however,
5.0 mM PMSF partially inhibited the proteolytic proces-
sing of 65 kDa protein (panel a, lane 6). This processing
was almost completely inhibited when the concentration of
PMSF was increased to 10 mM (panel a, lane 7). High
concentrations of pepstatin A (10 mM), trans-epoxysucci-
nyl-L-leucyl-amido(4-guanidino)butane (E-64) (1 mM) or
1,10-phenanthroline (20 mM) did not affect the conver-
sion of 65 kDa a1,2-mannosidase into a-mannosidase E-I
(panel b, lanes 2–4). Addition of 0.5 mM EGTA partially
inhibited the proteolytic processing (panel b, lane 5), and
almost complete inhibition occurred using 1.0 mM EGTA
(panel b, lane 6). The EGTA effect was prevented by the
addition of 3 mM CaCl2 (panel b, lane 7). Mock controls
containing preimmune serum (panels a and b, lane 8) or
lacking the primary antibodies (panels a and b, lane 9) run
in parallel gave no detectable signals. Therefore a Ca
2+-
dependent proteolysis is required for the processing of ER
a1,2-mannosidase activity into E-I.
Conversion of 65 kDa a1,2-mannosidase into
enzyme E-I by Kex2
The Golgi protease activity that processed the 65 kDa a1,2-
mannosidase into a1,2-mannosidase E-I was sensitive to
high concentrations of PMSF and EGTA. This inhibition
profile is similar to that observed for the Ca
2+-dependent
protease Kex2 (Fuller et al., 1988, 1989). Hence, we
compared the a-mannosidase activity distribution in a C.
albicans kex2D null mutant and in the wild-type strain
Fig. 4. Immunodetection of a1,2-mannosidase and some organ-
elle markers in fractions separated as indicated in Fig. 3. Protein
samples (10 mg) of a-mannosidase peaks from C. albicans and S.
cerevisiae were separated by SDS-PAGE, electrotransferred to
nitrocellulose membranes and immunodetected with anti-a1,2-
mannosidase and organelle markers as described in Methods.
Controls used rabbit pre-immune serum (Pre-immune serum), anti-
rabbit IgG-horseradish peroxidase (Rabbit IgG-HRP) or anti-
mouse IgG-horseradish peroxidase (Mouse IgG-HRP).
Fig. 5. Immunodetection of a1,2-mannosidase in cell homoge-
nates from mns1D null mutant, wild-type strain and reintegrant
control. Cell homogenates from strains NGY152 (wild-type strain,
lanes 1 and 4), HMY5 (mns1D null mutant, lane 2), and HMY6
(reintegrant control, lanes 3 and 5) were prepared as described in
Methods, and 25 mg protein samples were separated by SDS-
PAGE, electrotransferred to nitrocellulose membranes and immu-
nodetected with anti-a1,2-mannosidase (lanes 1–3) or pre-
immune (lanes 4 and 5) sera.
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94.6±5.3 nmol 4-methylumbelliferone (MU) min
21
(mg total protein)
21], 46% of the total activity was present
in a soluble form as previously demonstrated (Mora-
Montes et al., 2006); however in the kex2D null mutant
[total a-mannosidase activity 90.8±4.8 nmol MU min
21
(mg total protein)
21] more than 99% of the a-mannosi-
dase activity was associated with the mixed-membrane
fraction. When wild-type or kex2D null mutant cells were
broken in the presence of 1 mM EGTA, the a-mannosidase
distribution was similar to that of untreated cells. These
results suggest that Kex2 participates in the generation of
a-mannosidase E-I. To determine whether Kex2 was able to
process the 65 kDa a1,2-mannosidase into E-I, incubations
of purified 65 kDa a1,2-mannosidase from mixed-mem-
brane fraction and recombinant Kex2 from S. cerevisiae
were carried out, and analysed in zymograms using the
fluorogenic substrate MUaMan (see Methods). The results,
illustrated in Fig. 8, indicate that Kex2 processed the
membrane-bound 65 kDa a1,2-mannosidase into a-man-
nosidase E-I (lane 3), and this proteolytic cleavage was
sensitive to EGTA (lane 4). The 65 kDa a1,2-mannosidase
and E-I were run as controls (lanes 1 and 2). Similar results
were obtained when we analysed the products with the
anti-a1,2-mannosidase antibodies, or when we performed
the reactions using ER membrane-bound a1,2-mannosi-
dase from C. glabrata or recombinant Kex2 from C.
albicans or C. glabrata (data not shown). However,
recombinant Kex2 failed to hydrolyse the ER membrane-
bound a1,2-mannosidase from S. cerevisiae (data not
shown).
a-Mannosidase of 52 kDa generated by Kex2 processing
(Fig. 8, lane 3) and the previously purified a-mannosidase
E-I (Fig. 2) were subjected to N-terminal sequencing, and
for both proteins the identical amino acid sequence Asp-
Trp-Ile-Lys-Asn-Asp-Leu-Asp-Tyr-Thr-Phe-Asp-Tyr-Asn-
Val-Asn-Thr-Phe-Glu was obtained. This sequence was
localized at position 103–121 within the sequence for the
MNS1 product. Therefore, the same Kex2-dependent
proteolytic product was apparently generated in vitro and
in vivo.
Effect of monensin on free N-oligosaccharides
present in the cytosol
To obtain further insights into the role of a1,2-mannosi-
dase E-I in the cytosolic compartment, the soluble fraction
of protoplasts of C. albicans was recovered after fractiona-
tion in a continuous, 10–65% sucrose density gradient
(typically fractions 1–4) and was analysed by high-
performance anion-exchange chromatography (see
Methods). M8B and M7B were both present in the cytosol,
representing 21% and 79% of the total free N-oligosac-
charides, respectively (Table 3). When protoplasts of C.
albicans were treated with monensin, almost all the
cytosolic a-mannosidase E-I was absent and the levels of
M7B decreased to 3% of the total content of cytosolic free
N-oligosaccharides. This was accompanied by an increase
in the M8B levels (Table 3). Similar results were obtained
using protoplasts of C. albicans CAI4, SC5314 (data not
shown) and C. glabrata (Table 3). When similar assays
were performed using protoplasts of S. cerevisiae, C.
albicans kex2D null mutant or C. glabrata kex2D null
mutant, only M8B was detected in the cytosolic compart-
ment (Table 3). Therefore the generation of M7Bw a s
associated with the presence of a1,2-mannosidase E-I in the
cytosol.
DISCUSSION
Core-N-glycan processing enzymes are of major import-
ance to the growth and viability of fungi and play key roles
Fig. 6. Distribution of a-mannosidase activity of monensin-treated
homogenates from C. albicans and S. cerevisiae. Details as for Fig.
3, but the protoplasts from C. albicans (a) or S. cerevisiae (b) were
incubated with 10 mM monensin for 1 h at 37 6C before the
homogenization and separation in a continuous 10–65% (w/w)
sucrose density gradient. a-Mannosidase activity [nmol MU min
”1
(mg protein)
”1] using MUaMan as substrate (open symbols) and
the sucrose concentration (filled symbols) are indicated.
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albicans a-mannosidases showed that two activities could
be identified and that about 85% of soluble a1,2-
mannosidase activity corresponds to enzyme E-II (Mora-
Montes et al., 2004). Here, cell disruption in the presence
of pepstatin A generated membrane fractions with
increased levels of a-mannosidase activity at the expense of
a proportional decrease in the amount of soluble activity,
which was enriched with a1,2-mannosidase E-I. These
results suggest that pepstatin A inhibited the formation of
a-mannosidase E-II. Hence, it is most likely that this
enzyme corresponds to a soluble form of the membrane-
bound a-mannosidase which is generated during sample
preparation. Addition of pepstatin A did not affect the
biochemical properties of purified a1,2-mannosidase E-I,
which showed a molecular mass and N-mannan core
processing similar to that previously described (Mora-
Montes et al., 2006). Accordingly, E-I can be classified in
the glycosyl hydrolase family 47. The relationship of the
23 kDa polypeptide with the purified enzyme remains
undetermined.
Density-gradient centrifugation assays indicated that a1,2-
mannosidase activity of C. albicans protoplasts was
associated with fractions with densities in the range
reported for cytosolic, Golgi and ER compartments
(Beaufay et al., 1974; Chrispeels et al., 1982; Chrispeels,
1983; Harris & Waters, 1996). This distribution contrasts
with that exhibited by a similar homogenate from S.
cerevisiae centrifuged under the same conditions, where a-
mannosidase activity was separated into two peaks with
densities in the range reported for Golgi and ER
membranes.
Hexokinase I distribution confirmed that peak I was
enriched with components from the cytosolic compart-
Fig. 7. Cleavage of 65 kDa a1,2-mannosidase into a1,2-mannosidase E-I by a Golgi-associated protease activity. Aliquots
containing 10 mg protein were separated by SDS-PAGE, electrotransferred to nitrocellulose membranes and immunodetected
with anti-a1,2-mannosidase (a, b, lanes 1–7), rabbit preimmune (a, b, lane 8) or anti-rabbit IgG-horseradish peroxidase (a, b,
lane 9) sera. Lanes 1 and 2 in (a) correspond to samples from a-mannosidase peaks 2 and 3, respectively, separated after
treatment with monensin. The samples were incubated with 0.5% Triton X-100 for 1 h at 37 6C before the electrophoresis.
Lane 3 in (a) and lane 1 in (b) contain protein samples from peaks 2 and 3 pooled and incubated as described above. The
incubations of both peaks were also carried out in the presence of 0.5, 1.0, 5.0 and 10 mM PMSF (a, lanes 4–7); 10 mM
pepstatin A (b, lane 2); 1 mM E-64 (b, lane 3); 20 mM 1,10-phenanthroline (b, lane 4); 0.5 and 1.0 mM EGTA (b, lanes 5 and
6); 1.0 mM EGTA plus 3 mM CaCl2 (b, lane 7).
Fig. 8. Proteolytic processing of 65 kDa a1,2-mannosidase into
a1,2-mannosidase E-I by recombinant Kex2. Samples (20 mg) of
the purified 65 kDa a1,2-mannosidase were incubated with 3 mg
recombinant Kex2 from S. cerevisiae for 1 h at 37 6C in the
absence (lane 3) or presence (lane 4) of 1 mM EGTA. The
reactions were analysed by analytical zymograms with MUaMan as
described in Methods. Control reactions containing only purified
a1,2-mannosidase E-I (lane 1) or 65 kDa a1,2-mannosidase (lane
2) were run in parallel.
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marker gave a strong signal in peak 2. This peak was also
enriched with the Golgi form of CPY (Bryant & Stevens,
1998), which has a molecular mass (70 kDa) significantly
higher than that of 61.1 kDa predicted for this enzyme
(Mukhtar et al., 1992). Peak 3 gave strong signals with ER
but not Golgi and cytoplasmic markers, thus supporting
the nature of these vesicles. The 68 kDa protein detected
with the anti-CPY serum most likely corresponds to the ER
form. Thus, the presence of hexokinase I and the absence of
CPY and calnexin indicate that peak 1 did not contain
vesicles or elements derived from the ER or Golgi. Because
the marker for the Golgi compartment corresponds to a
protein associated with the cytosolic face of the Golgi
complex (Bloom & Brashear, 1989), it is possible that the
barely detectable band in peak 1 represents trace quantities
of the protein that is detached from the Golgi membranes.
These results indicate that a1,2-mannosidase E-I is
localized in the cytosolic cell fraction.
The anti-a1,2-mannosidase serum detected two polypep-
tides, of 52 kDa and 65 kDa, in Golgi and ER-associated
vesicles, respectively. The molecular mass of 65 kDa is
consistent with that predicted for the C. albicans MNS1
gene product, and our results confirmed that this protein is
Mns1, the ER membrane-associated a1,2-mannosidase
(GenBank/EBI accession AY167027; Mora-Montes et al.,
2007). Its presence in the ER compartment probably
results, as has been described for S. cerevisiae (Massaad &
Herscovics, 2001), from a Rer1-dependent mechanism of
localization. The enzyme E-I was not immunodetected in a
C. albicans mns1D null mutant; thus, this gene encodes
both a1,2-mannosidases. The members of glycosyl hydro-
lase family 47 that have so far been identified in the C.
albicans genome (Arnaud et al., 2005) are MNS1 and
orf19.834. The latter is homologous to S. cerevisiae MNL1,
which encodes an ER mannosidase-like protein required
for degradation of glycoproteins (Jakob et al., 2001;
Nakatsukasa et al., 2001). However, these products have
low values of identity (17.5%) and similarity (28.5%).
MNS1 and AMS1, the putative gene encoding the vacuolar
a-mannosidase, showed identity and similarity of only
11.6% and 19%, respectively. These data reinforce the
observation that both 65 kDa and 52 kDa polypeptides are
encoded by MNS1.
Monensin blocked the transport of ER a1,2-mannosidase
to Golgi and led to a depletion in the levels of a1,2-
mannosidase E-I in the cytosolic compartment. These
results suggest that the soluble a1,2-mannosidase is
generated in the Golgi complex by proteolytic processing
of the 65 kDa membrane-associated protein, and then is
transported to the cytosolic compartment. Indeed, our
results indicate that the 65 kDa membrane-bound enzyme
was processed to a1,2-mannosidase E-I by Golgi Kex2
serine protease, which activates precursors of secreted
proteins by an endoproteolytic cleavage at the C-terminus
of dibasic motifs (Newport et al., 2003). Moreover,
inhibition of Kex2 by EGTA during the cell-breaking
process did not change the a-mannosidase distribution in
wild-type cells, suggesting that a1,2-mannosidase E-I is
generated in vivo rather than in vitro. However, the
membrane-bound a1,2-mannosidase from S. cerevisiae
was not processed by Kex2. This is in agreement with
previous reports indicating that ER membrane-bound
a1,2-mannosidase is the unique isoform present in vivo
in S. cerevisiae (Jelinek-Kelly & Herscovics, 1988;
Herscovics, 1999a).
The N-terminal sequence of both the purified a1,2-
mannosidase E-I and the enzyme E-I proteolytically
generated by Kex2 was located between amino acids 103
and 121 of the MNS1 gene product. This predicts the
Table 3. Free N-oligosaccharides present in the cytosolic compartment
Organism Cytosolic free
N-oligosaccharides (mg)*
M8B (%)D M7B (%)D
C. albicans:
ATCC 26555 1.55±0.04d 21 79
ATCC 26555+monensind 1.50±0.08 97 3
kex2D 1.49±0.06 100 ND
kex2D+monensin 1.53±0.09 100 ND
C. glabrata:
ATCC 2001 1.38±0.09 19 81
ATCC 2001+monensin 1.32±0.08 98 2
kex2D 1.30±0.06 100 ND
kex2D+monensin 1.36±0.07 100 ND
S. cerevisiae 1.30±0.05 100 ND
S. cerevisiae+monensin 1.33±0.07 100 ND
*Per mg of cytosolic protein. The values represent the means±SD of at least three independent determinations.
DProportion of the total cytosolic free N-oligosaccharides. ND, Not detected.
dIndicates protoplasts treated with monensin as described in Methods.
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with a molecular mass of 52.8 kDa, containing all the
amino acids required for enzyme activity. These character-
istics are fulfilled by a1,2-mannosidase E-I. Kex2 carries
out the endoproteolysis at the C-terminus of dibasic amino
acid motifs (Lys-Arg and Arg-Arg) (Fuller et al., 1988).
However, the N-terminal end of E-I is not preceded by a
typical Kex2 recognition sequence. Instead, the sequences
Ser
99-Arg
100 and Ala
101-Arg
102 are present. In vitro and in
vivo studies have demonstrated that Kex2 can recognize
both of these non-canonical sequences, but with lower
affinity (Bevan et al., 1998; Brenner & Fuller, 1992). This
may explain why only around 45% of the a-mannosidase
activity was present as E-I. Hence, the results indicate that
Kex2 recognizes an atypical cleavage site on the ER
membrane-bound a1,2-mannosidase. The mechanism uti-
lized to transport the a1,2-mannosidase E-I to the cytosolic
compartment still remains to be determined. Fig. 9 shows a
model for the processing of membrane-bound a1,2-
mannosidase into enzyme E-I.
To gain further insights into the role of the cytosolic a1,2-
mannosidase, we determined the levels of free cytosolic N-
oligosaccharides in protoplasts treated and not treated with
the ionophore monensin, which blocks glycosylation by
affecting divalent cation transport into the Golgi. In
agreement with previous reports (Chantret et al., 2003),
protoplasts of S. cerevisiae showed only the presence of
M8B in the cytosolic preparations. It is believed that this N-
oligosaccharide is generated by deglycosylation of glyco-
proteins during the ERAD (Chantret et al., 2003). For
protoplasts of C. albicans,M 8B and M7B were detected in
the cytosolic compartment, representing 21% and 79% of
the total oligosaccharides, respectively. Protoplasts
depleted of enzyme E-I had reduced amounts of M7B
oligosaccharide and increased levels of M8B. These results
suggest that enzyme E-I is required for the trimming of
M8B into M7B. Similar results were obtained using
protoplasts of C. glabrata, indicating that ER membrane-
bound a1,2-mannosidase from this yeast can be processed
to a cytosolic isoform by Kex2. Similar results have been
reported in human cells, where the downregulation of
cytosolic a-mannosidase activity directly influences the
amount and the structure of the N-oligosaccharides
present in the cytosol (Suzuki et al., 2006).
The limited proteolysis of ER a1,2-mannosidase by Kex2
could represent a regulatory mechanism similar to that
recently described for the human ER a1,2-mannosidase
(Wu et al., 2007), with implications for the regulation of
ERAD, N-glycosylation and the degradation of cytosolic
free N-oligosaccharides. To our knowledge this is the first
report of a cytoplasmic a1,2-mannosidase in lower
eukaryotes belonging to family 47 of glycosyl hydrolases.
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